Range
32.04 - 32.04
Vol / Avg.
0.4K/7.7K
Div / Yield
-
52 Wk
27.9 - 44.42
Mkt Cap
1.4B
Payout Ratio
-
Open
32.04
P/E
-
EPS
-9.68
Shares
43.4M
Outstanding
43.4M
Total Float
-
Benzinga - Jun 2, 2021, 8:01AM
Benzinga - May 12, 2021, 9:03AM
Benzinga - May 3, 2021, 8:02AM
Benzinga - Apr 13, 2021, 8:02AM
Benzinga - Apr 9, 2021, 8:03AM
Benzinga - Mar 22, 2021, 5:51PM
Benzinga - Mar 22, 2021, 4:24PM
Benzinga - Mar 11, 2021, 9:11AM
Benzinga - Mar 11, 2021, 9:10AM
Benzinga - Jan 22, 2021, 4:09PM
Benzinga - Dec 15, 2020, 8:23AM
Benzinga - Dec 11, 2020, 9:05AM
Benzinga - Nov 13, 2020, 8:23AM
Benzinga - Nov 12, 2020, 9:02AM
Benzinga - Oct 13, 2020, 10:31AM
Benzinga - Aug 14, 2020, 9:20AM
Benzinga - Aug 13, 2020, 9:10AM
Benzinga - Jul 15, 2020, 11:17AM
Benzinga - Jul 6, 2020, 7:06AM
load more
Sector: Health Care.Industry: Biotechnology
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. Its products include soliqua 100/33/suliqua and adlyxin. The firm focuses on gastrointestinal diseases and metabolic diseases. Its product pipeline includes dasiglucagon, glepaglutide, and dual glucagon product candidates.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-24
REV
Q1 2021Est.ActualSurprise
EPS-1.010-0.940 0.0700
REV9.890M7.500M-2.390M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ZEALZealand Pharma1.49%1.4B

Zealand Pharma Frequently Asked Questions

Q

How do I buy Zealand Pharma (ZEAL) stock?

A

You can purchase shares of Zealand Pharma (NASDAQ: ZEAL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zealand Pharma's (ZEAL) competitors?

A

Other companies in Zealand Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Precigen (NASDAQ:PGEN), Replimune Group (NASDAQ:REPL), Humanigen (NASDAQ:HGEN) and Arcutis Biotherapeutics (NASDAQ:ARQT).

Q

What is the target price for Zealand Pharma (ZEAL) stock?

A

The latest price target for Zealand Pharma (NASDAQ: ZEAL) was reported by Morgan Stanley on November 13, 2020. The analyst firm set a price target for 44.00 expecting ZEAL to rise to within 12 months (a possible 37.33% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Zealand Pharma (ZEAL)?

A

The stock price for Zealand Pharma (NASDAQ: ZEAL) is $32.04 last updated Fri Jun 11 2021 19:47:25 GMT+0000 (Coordinated Universal Time).

Q

Does Zealand Pharma (ZEAL) pay a dividend?

A

There are no upcoming dividends for Zealand Pharma.

Q

When is Zealand Pharma (NASDAQ:ZEAL) reporting earnings?

A
Zealand Pharma’s Q2 earnings are confirmed for after-market on August 24, 2021.
Q

Is Zealand Pharma (ZEAL) going to split?

A

There is no upcoming split for Zealand Pharma.

Q

What sector and industry does Zealand Pharma (ZEAL) operate in?

A

Zealand Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.